TR200201174T2 - Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler. - Google Patents

Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.

Info

Publication number
TR200201174T2
TR200201174T2 TR2002/01174T TR200201174T TR200201174T2 TR 200201174 T2 TR200201174 T2 TR 200201174T2 TR 2002/01174 T TR2002/01174 T TR 2002/01174T TR 200201174 T TR200201174 T TR 200201174T TR 200201174 T2 TR200201174 T2 TR 200201174T2
Authority
TR
Turkey
Prior art keywords
xanthan gum
pharmaceutical compositions
compositions containing
fluoroquinolone antibiotic
antibiotic medicine
Prior art date
Application number
TR2002/01174T
Other languages
English (en)
Inventor
P. Kabra Bhagwati
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of TR200201174T2 publication Critical patent/TR200201174T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Florokinolon antibiyotik ilaci, iksantan zamki ve florokinolon antibiyotik ilaci ile iksantan zamkini uyumlu yapmak için yeterli miktarda suda çözünür kalsiyum tuzu içeren farmasötik bilesimler ifsa edilmistir.
TR2002/01174T 1999-11-01 2000-10-10 Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler. TR200201174T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16269399P 1999-11-01 1999-11-01

Publications (1)

Publication Number Publication Date
TR200201174T2 true TR200201174T2 (tr) 2002-08-21

Family

ID=22586735

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01174T TR200201174T2 (tr) 1999-11-01 2000-10-10 Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.

Country Status (19)

Country Link
US (1) US6331540B1 (tr)
EP (1) EP1225898B1 (tr)
JP (1) JP2003513046A (tr)
KR (1) KR20020048967A (tr)
CN (1) CN1384745A (tr)
AR (1) AR026227A1 (tr)
AT (1) ATE243038T1 (tr)
AU (1) AU8008300A (tr)
BR (1) BR0015256A (tr)
CA (1) CA2386822A1 (tr)
DE (1) DE60003445T2 (tr)
DK (1) DK1225898T3 (tr)
ES (1) ES2199873T3 (tr)
HK (1) HK1045940A1 (tr)
MX (1) MXPA02004349A (tr)
PL (1) PL354928A1 (tr)
PT (1) PT1225898E (tr)
TR (1) TR200201174T2 (tr)
WO (1) WO2001032181A2 (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009922A1 (en) * 2001-01-27 2005-01-13 Carlson Paul E. Stable aqueous antimicrobial suspension
ES2388170T3 (es) * 2001-08-24 2012-10-09 Uvic Industry Partnerships Inc. Proaerolisina que contiene secuencias de activación de proteasa y métodos de uso para el tratamiento del cáncer de próstata
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8784789B2 (en) * 2002-07-31 2014-07-22 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
NZ563417A (en) * 2005-05-18 2012-01-12 Mpex Pharmaceuticals Inc Aerosolized fluoroquinolones and uses thereof
JP5245078B2 (ja) * 2006-10-12 2013-07-24 杏林製薬株式会社 ガチフロキサシンの眼内移行性を向上させた水性液剤
KR20110017844A (ko) 2008-03-31 2011-02-22 교린 세이야꾸 가부시키 가이샤 가티플록사신을 함유하는 수성 액
EP2260848A4 (en) * 2008-03-31 2013-02-13 Kyorin Seiyaku Kk WATER-CONTAINING LIQUID WITH GATIFLOXACIN, METHOD FOR THE PRODUCTION THEREOF, AND METHOD FOR PREVENTING THE DEPOSITION OF DEPOSITS DURING THE STORAGE OF THE WATER-CONTAINING LIQUID AT LOW TEMPERATURE OR WHEN FREEZING / DEFROSTING THE WATER-CONTAINING LIQUID
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
CA2739897C (en) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
DK2473170T3 (da) 2009-09-04 2019-08-12 Horizon Orphan Llc Anvendelse af aerosoliseret levofloxacin til behandling af cystisk fibrose
RU2500414C1 (ru) * 2010-02-24 2013-12-10 Моринага Милк Индастри Ко., Лтд. Антибактериальный вспомогательный агент, содержащий экстракт комбу в качестве активного ингредиента, антибактериальная композиция и пищевой продукт или напиток
US9050357B2 (en) * 2010-03-08 2015-06-09 Cp Kelco U.S., Inc. Compositions and methods for producing consumables for patients with dysphagia
GR1008168B (el) 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
JP6602534B2 (ja) * 2013-09-27 2019-11-06 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6538322B2 (ja) * 2013-09-27 2019-07-03 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6713728B2 (ja) * 2015-05-01 2020-06-24 三栄源エフ・エフ・アイ株式会社 液状増粘剤
KR102869384B1 (ko) 2017-07-07 2025-10-15 에피센트알엑스, 인코포레이티드 치료제의 비경구 투여를 위한 조성물
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods
US11298315B2 (en) 2020-08-26 2022-04-12 Somerset Therapeutics, Llc. Triamcinolone and moxifloxacin compositions
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700451A (en) 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3944427A (en) 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3784712A (en) 1970-12-23 1974-01-08 Gen Foods Corp Gum gelling system xanthan-tara dessert gel
CA1070629A (en) 1975-11-10 1980-01-29 Allen I. Laskin Process for modifying biopolymers
US4135979A (en) 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
GB8318403D0 (en) 1983-07-07 1983-08-10 Sutherland I W Gel-forming polysaccharides
FR2551087B1 (fr) 1983-08-30 1986-03-21 Rhone Poulenc Spec Chim Procede de traitement d'une solution de polysaccharide et son utilisation
DE3335593A1 (de) 1983-09-30 1985-04-11 Diamalt AG, 8000 München Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4647470A (en) 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
FR2618333B1 (fr) 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US4814160A (en) 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3843416A1 (de) 1988-12-23 1990-06-28 Wolff Walsrode Ag Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung
CA2021414C (en) 1989-07-25 2004-09-28 Daniel H. Doherty Genetic control of acetylation and pyruvylation of xanthan gum
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
DK0495421T3 (da) 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
DE69224071T2 (de) * 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5473062A (en) 1992-10-29 1995-12-05 Takeda Chemical Industries, Ltd. Process for producing purified xanthan gum
JP3228315B2 (ja) 1993-04-23 2001-11-12 信越化学工業株式会社 キサンタンガムの汚染生菌数を減少させる方法
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
JPH09510961A (ja) 1994-01-14 1997-11-04 ジュニア シャヒニアン，リー 持続性および長期間の角膜鎮痛の方法
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
ES2258495T3 (es) 1994-04-08 2006-09-01 Qlt Usa, Inc. Composiciones de administracion liquida de farmacos.
US5523301A (en) 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
CN1162148C (zh) 1994-08-30 2004-08-18 阿尔康实验室公司 含有纤维素醚的热凝胶药物转运载体
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
WO1998053809A1 (en) 1997-05-30 1998-12-03 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
EP1024810A4 (en) 1997-06-26 2003-06-11 Merck & Co Inc METHOD FOR OPTIMIZING RETINAL AND THE HEALTH OF THE OPTICAL NERVE
CA2302561C (en) * 1997-09-12 2006-02-14 The Procter & Gamble Company Cleansing and conditioning article for skin or hair
PT1069913E (pt) * 1998-04-07 2003-11-28 Alcon Mfg Ltd Composicoes oftalmicas gelificantes contendo goma xantana
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same

Also Published As

Publication number Publication date
ES2199873T3 (es) 2004-03-01
EP1225898B1 (en) 2003-06-18
MXPA02004349A (es) 2003-09-22
HK1045940A1 (zh) 2002-12-20
DE60003445T2 (de) 2003-12-24
KR20020048967A (ko) 2002-06-24
CA2386822A1 (en) 2001-05-10
WO2001032181A2 (en) 2001-05-10
PT1225898E (pt) 2003-10-31
AU8008300A (en) 2001-05-14
AR026227A1 (es) 2003-01-29
WO2001032181A3 (en) 2002-05-02
EP1225898A2 (en) 2002-07-31
DE60003445D1 (de) 2003-07-24
BR0015256A (pt) 2002-06-18
ATE243038T1 (de) 2003-07-15
PL354928A1 (en) 2004-03-22
JP2003513046A (ja) 2003-04-08
DK1225898T3 (da) 2003-09-15
US6331540B1 (en) 2001-12-18
CN1384745A (zh) 2002-12-11

Similar Documents

Publication Publication Date Title
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
NO20014035L (no) System for oral administrasjon av medikament
DE60205749D1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BR0210139A (pt) Composições farmacêuticas
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
UY28175A1 (es) Formulaciones farmaceuticas liquidas de palonosetron
AU2003211951A1 (en) N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
TR200003108T2 (tr) İlaç kompozisyonları
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
MY140953A (en) Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with pradofloxacin and intrinsically viscous gelling agents as thickening agents
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
AU2003290015A1 (en) Mastitis treatment
ATE284878T1 (de) Pharmazeutische verbindungen mit serotonin rezeptor aktivität
BRPI0418726A (pt) naftalenossulfonato de clopidogrel cristalino ou hidrato do mesmo, método para sua preparação e composição farmacêutica contendo o mesmo
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients